最新报道:MEI Pharma has become the first U.S. public company to adopt Litecoin (LTC) as its primary reserve asset, acquiring $100 million worth of LTC through a PIPE offering. The company is now advised by Litecoin creator Charlie Lee and trading firm GSR on treasury strategy and asset management. MEI cited Litecoin's 13-year uptime, low fees, and institutional adoption via platforms like BitPay and PayPal as key strategic advantages. The firm has already recorded a $15 million unrealized gain, highlighting crypto's volatility, while its move could influence corporate and regulatory views on digital assets.